Baader Bank Aktiengesellschaft Abbott Laboratories Transaction History

Baader Bank Aktiengesellschaft

$1.45 Billion
Q4 2024

A detailed history of Baader Bank Aktiengesellschaft transactions in Abbott Laboratories stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 5,139 shares of ABT stock, worth $657,432. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,139

Previous 5,369 4.28%

Holding current value

$657,432

Previous $612,000 5.07%

% of portfolio

0.04%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$111.93 - $119.39 $25,743 - $27,459	-230 Reduced 4.28%	5,139 $581,000
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $790,953 - $933,699	-7,904 Reduced 59.55%	5,369 $612,000
Q2 2024 Jul 17, 2024	SELL	$100.73 - $112.44 $37,975 - $42,389	-377 Reduced 2.76%	13,273 $1.38 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $2,409 - $2,661	-22 Reduced 0.16%	13,650 $1.55 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $19,390 - $23,736	-215 Reduced 1.55%	13,672 $1.5 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $286 - $343	-3 Reduced 0.02%	13,887 $1.34 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $8,163 - $9,095	-81 Reduced 0.58%	13,890 $1.51 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $31,092 - $36,597	321 Added 2.35%	13,971 $1.41 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.3 Million - $1.52 Million	13,650 New	13,650 $1.5 Million
Q3 2022 May 04, 2023	SELL	$96.76 - $112.03 $643,454 - $744,999	-6,650 Reduced 48.72%	7,000 $677,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $720,614 - $870,992	-7,060 Reduced 67.5%	3,400 $369,000
Q1 2022 May 18, 2022	BUY	$114.02 - $139.04 $1.19 Million - $1.45 Million	10,460 New	10,460 $1.24 Million

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.

Account

Baader Bank Aktiengesellschaft Abbott Laboratories Transaction History